GPI pulse™ 2.0 Wins Most Innovative Pricing & Market Access Analytics Platform 2021

GPI are thrilled to announce the award of Global Health Pharma’s (GHP) Most Innovative Pricing & Market Access Analytics Platform for GPI pulse™ 2.0.

View winners list

GPI’s suite of technology and bespoke service offerings are powered by GPI pulse™ 2.0, a solution that harnesses the power of technology, data, and collective expertise to drive effective and efficient access to medicines with faster insights and sustainable pricing strategies.

As a team of leading domain specialists, GPI provide high quality, curated insights and recommendations on global drug pricing strategy, market access optimisation, asset evaluation, value perception and payer behaviour.

Like with any industries, there are challenges to be met and the most significant challenge recently for GPI is the fact that pricing and market access is constantly evolving, therefore the solutions the company builds must withstand and adapt to shifts in the environment. To overcome this challenge, GPI’s CEO, Preeti Patel, explains that GPI heavily invests in its team, its methods, and its technology.

“Our team is built of individuals from diverse backgrounds and skillsets,” she says. “We are continually doing research to improve and build solutions, and we use agile development processes – all allowing us to support our clients through a complex and ever-changing landscape.”

GPI’s flagship offering, GPI pulse™ 2.0, is one such example. Having recently launched an updated version of its value, price and market access data analytics platform, called GPI pulse™ 2.0, the solution offers a more intuitive, seamless experience with two powerful modules in one analytics platform.

“GPI pulse™ 2.0 is meticulously engineered to deliver robust pricing and market access insights with enhanced algorithms and can be used as part of our unique market access solutions, or as a standalone analytics too“

Preeti Patel, GPI CEO

In fact, GPI pulse™ 2.0 is so effective that it has now been voted Most Innovative Pricing & Market Access Analytics Platform 2021 in the Healthcare and Pharmaceutical Award 2021. A fantastic accolade for GPI, and a reflection of the hard work, vision and innovation of the GPI team, resulting in a unique market access solution that helps to bring sustainable market access strategies, faster.

“Our mission is drive effective and efficient access to medicines with faster insights and sustainable pricing strategies. With this in mind, our most significant breakthrough with GPI pulse™ 2.0 was completely reimagining our entire data architecture. Although it was not the easy route, the process has enabled us to integrate even more relevant data domains into our platform, delivering more multifaceted analysis and a unique view pricing and market access.”  

Preeti Patel, GPI CEO

About GPI pulse™ 2.0

GPI pulse™ 2.0 is a dynamic value, price, and access analytics platform, utilising powerful algorithms to combine multiple data streams in a way that will give you unique insight into the full market access journey. The platform is designed to be used as part of GPI’s comprehensive solution for pharma pricing and market access strategy, but can also be used to create efficient, robust insights as a standalone analytics tool. The data and analytics provided by GPI pulse™ 2.0, are at the centre of the GPI full product lifecycle pricing and market access strategy offering.

---

About Global Pricing

GPI is a market leader in analytics and innovative solutions for biopharma pricing and market access.  Founded in 2015 and headquartered in London, GPI supports price decision-making throughout the lifecycle and helps the industry achieve day-to-day operational improvement and market access excellence.  By harnessing the power of technology, data, and collective expertise, GPI drives effective and efficient access to medicines with faster insights and sustainable pricing strategies.